Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1996 Dec;149(6):1963–1970.

Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality.

E S Yi 1, S T Williams 1, H Lee 1, D M Malicki 1, E M Chin 1, S Yin 1, J Tarpley 1, T R Ulich 1
PMCID: PMC1865350  PMID: 8952531

Abstract

Keratinocyte growth factor (KGF) is a growth factor for type II pneumocytes. Type II pneumocyte hyperplasia, a common reaction to lung injury, has been postulated to play an important role in lung repair. The potential protective effect of KGF was therefore studied in rat models of radiation- and bleomycin-induced lung injury. Intratracheal instillation of KGF (5 mg/kg) 72 and 48 hours before 18 Gy of bilateral thoracic irradiation did not significantly improve survival, although histology showed less pneumonitis and fibrosis in KGF-pretreated as compared with control-irradiated rats. Intratracheal pretreatment with KGF in rats receiving intratracheal bleomycin (2.5 U) improved survival at 3 weeks to 100% (20/20 rats) from 40% (8/20 rats) in controls. All KGF-pretreated rats receiving bleomycin were well at 3 weeks and without histological evidence of pulmonary fibrosis whereas the 8 surviving control rats exhibited severe respiratory distress. Finally, in the most lethal challenge to the lung, rats pretreated with intratracheal KGF or saline were challenged with a combination of bleomycin (1.5 U) and bilateral thoracic irradiation (18 Gy). KGF-pretreated rats did not begin to die or show signs of respiratory distress until 7 weeks, whereas all saline-pretreated control rats receiving radiation and bleomycin died within approximately 4 weeks with severe respiratory distress and weight loss. In conclusion, radiation- and bleomycin-induced pulmonary injury and respiratory death are ameliorated by KGF pretreatment, suggesting a protective role for KGF-induced type II pneumocyte proliferation in lung injury.

Full text

PDF
1963

Images in this article

1965Figure 2
on p.1965
1966Figure 4
on p.1966
1967Figure 6
on p.1967
1968Figure 8
on p.1968
1969Figure 9
on p.1969

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson I. Y., Bowden D. H. The type 2 cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen. Lab Invest. 1974 Jan;30(1):35–42. [PubMed] [Google Scholar]
  2. Adamson I. Y., Young L., Bowden D. H. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol. 1988 Feb;130(2):377–383. [PMC free article] [PubMed] [Google Scholar]
  3. Brauchle M., Angermeyer K., Hübner G., Werner S. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene. 1994 Nov;9(11):3199–3204. [PubMed] [Google Scholar]
  4. Crouch E. Pathobiology of pulmonary fibrosis. Am J Physiol. 1990 Oct;259(4 Pt 1):L159–L184. doi: 10.1152/ajplung.1990.259.4.L159. [DOI] [PubMed] [Google Scholar]
  5. Finch P. W., Cunha G. R., Rubin J. S., Wong J., Ron D. Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dyn. 1995 Jun;203(2):223–240. doi: 10.1002/aja.1002030210. [DOI] [PubMed] [Google Scholar]
  6. Finch P. W., Rubin J. S., Miki T., Ron D., Aaronson S. A. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science. 1989 Aug 18;245(4919):752–755. doi: 10.1126/science.2475908. [DOI] [PubMed] [Google Scholar]
  7. Haschek W. M., Reiser K. M., Klein-Szanto A. J., Kehrer J. P., Smith L. H., Last J. A., Witschi H. P. Potentiation of butylated hydroxytoluene-induced acute lung damage by oxygen. Cell kinetics and collagen metabolism. Am Rev Respir Dis. 1983 Jan;127(1):28–34. doi: 10.1164/arrd.1983.127.1.28. [DOI] [PubMed] [Google Scholar]
  8. Mason I. J., Fuller-Pace F., Smith R., Dickson C. FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions. Mech Dev. 1994 Jan;45(1):15–30. doi: 10.1016/0925-4773(94)90050-7. [DOI] [PubMed] [Google Scholar]
  9. Moseley P. L., Shasby D. M., Brady M., Hunninghake G. W. Lung parenchymal injury induced by bleomycin. Am Rev Respir Dis. 1984 Dec;130(6):1082–1086. doi: 10.1164/arrd.1984.130.6.1082. [DOI] [PubMed] [Google Scholar]
  10. Panos R. J., Bak P. M., Simonet W. S., Rubin J. S., Smith L. J. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J Clin Invest. 1995 Oct;96(4):2026–2033. doi: 10.1172/JCI118250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Panos R. J., Rubin J. S., Csaky K. G., Aaronson S. A., Mason R. J. Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J Clin Invest. 1993 Aug;92(2):969–977. doi: 10.1172/JCI116673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Panos R. J., Suwabe A., Leslie C. C., Mason R. J. Hypertrophic alveolar type II cells from silica-treated rats are committed to DNA synthesis in vitro. Am J Respir Cell Mol Biol. 1990 Jul;3(1):51–59. doi: 10.1165/ajrcmb/3.1.51. [DOI] [PubMed] [Google Scholar]
  13. Rosiello R. A., Merrill W. W. Radiation-induced lung injury. Clin Chest Med. 1990 Mar;11(1):65–71. [PubMed] [Google Scholar]
  14. Sugahara K., Rubin J. S., Mason R. J., Aronsen E. L., Shannon J. M. Keratinocyte growth factor increases mRNAs for SP-A and SP-B in adult rat alveolar type II cells in culture. Am J Physiol. 1995 Sep;269(3 Pt 1):L344–L350. doi: 10.1152/ajplung.1995.269.3.L344. [DOI] [PubMed] [Google Scholar]
  15. Thet L. A., Parra S. C., Shelburne J. D. Sequential changes in lung morphology during the repair of acute oxygen-induced lung injury in adult rats. Exp Lung Res. 1986;11(3):209–228. doi: 10.3109/01902148609064297. [DOI] [PubMed] [Google Scholar]
  16. Ulich T. R., Yi E. S., Longmuir K., Yin S., Biltz R., Morris C. F., Housley R. M., Pierce G. F. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J Clin Invest. 1994 Mar;93(3):1298–1306. doi: 10.1172/JCI117086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Werner S., Peters K. G., Longaker M. T., Fuller-Pace F., Banda M. J., Williams L. T. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6896–6900. doi: 10.1073/pnas.89.15.6896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Witsch I. H. Proliferation of type II alveolar cells: a review of common responses in toxic lung injury. Toxicology. 1976 Mar;5(3):267–277. doi: 10.1016/0300-483x(76)90046-9. [DOI] [PubMed] [Google Scholar]
  19. Witschi H. Role of the epithelium in lung repair. Chest. 1991 Mar;99(3 Suppl):22S–25S. doi: 10.1378/chest.99.3_supplement.22s. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES